TAFI antigen level variability in young healthy Asian Indians; First report from Asia
作者： Arijit Biswas , Ravi Ranjan , Arvind Meena , Suhail Akhter , Noemie Saut
DOI: 10.1016/J.CLINBIOCHEM.2008.03.009
关键词:
摘要: Thrombin Activatable Fibrinolytic Inhibitor (TAFI) is a plasma protein, which inhibits fibrinolysis by removing carboxyterminal lysine residues from partially degraded fibrin thereby decreasing plasminogen binding on its surface. In this study we have investigated the antigenic level variability (Inter and Intraindividual) of Fibrinolysis in 120 healthy Asian Indians since no data available regarding population. TAFI antigen levels did not show normal distribution our population (p < 0.001). Median were found to be 11.683 µg/ml. It ranged 33.9–202.5%of pool (3.9–23.5 µg/ml). showed high Indian (coefficient variation: 37.4%). stable intraindividually (p = 0.218).
elsevier.com
sci-hub.se 参考文章(12)
L Bajzar, ME Nesheim, PB Tracy, The Profibrinolytic Effect.of Activated Protein C in Clots Formed From Plasma Is TAFI-Dependent Blood. ,vol. 88, pp. 2093- 2100 ,(1996) , 10.1182/BLOOD.V88.6.2093.BLOODJOURNAL8862093
Mats Stromqvist, Katinka Schatteman, Judith Leurs, Robert Verkerk, Jan-Olof Andersson, Thord Johansson, Simon Scharpe, Dirk Hendriks, None, Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma Thrombosis and Haemostasis. ,vol. 85, pp. 12- 17 ,(2001) , 10.1055/S-0037-1612656
The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients Seminars in Thrombosis and Hemostasis. ,vol. 29, pp. 575- 583 ,(2003) , 10.1055/S-2004-815625
Laurent O Mosnier, Marc GLM Elisen, Bonno N Bouma, Joost CM Meijers, None, Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation. Thrombosis and Haemostasis. ,vol. 86, pp. 1057- 1064 ,(2001) , 10.1055/S-0037-1616533
Rendrik F Franco, Maria G Fagundes, JC Meijers, Pieter H Reitsma, Dayse Lourenço, Vânia Morelli, Francisco H Maffei, Iracema C Ferrari, Carlos E Piccinato, Wilson A Silva, Marco A Zago, Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis Haematologica. ,vol. 86, pp. 510- 517 ,(2001)
Corinne Frère, David-Alexandre Tregouet, Pierre-Emmanuel Morange, Noémie Saut, Dinar Kouassi, Irène Juhan-Vague, Laurence Tiret, Marie-Christine Alessi, Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study. Blood. ,vol. 108, pp. 1562- 1568 ,(2006) , 10.1182/BLOOD-2006-01-008094
Xiaoyan Guo, Akihiro Morioka, Yoko Kaneko, Noriko Okada, Kyoko Obata, Tomoyuki Nomura, William Campbell, Hidechika Okada, Arginine carboxypeptidase (CPR) in human plasma determined with sandwich ELISA. Microbiology and Immunology. ,vol. 43, pp. 691- 698 ,(1999) , 10.1111/J.1348-0421.1999.TB02457.X
Mireille Henry, Hélène Aubert, Pierre E. Morange, Isabelle Nanni, Marie-Christine Alessi, Laurence Tiret, Irène Juhan-Vague, Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood. ,vol. 97, pp. 2053- 2058 ,(2001) , 10.1182/BLOOD.V97.7.2053
Corinne Frère, Pierre Emmanuel Morange, Noémie Saut, David Alexandre Tregouet, Mariana Grosley, Jérôme Beltran, Irène Juhan-Vague, Marie-Christine Alessi, Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact. Thrombosis and Haemostasis. ,vol. 94, pp. 373- 379 ,(2005) , 10.1160/TH04-08-0497
Sabine Eichinger, Verena Schönauer, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Barbara Schneider, Peter Quehenberger, Paul A. Kyrle, Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Blood. ,vol. 103, pp. 3773- 3776 ,(2004) , 10.1182/BLOOD-2003-10-3422